v3.25.2
SEGMENT REPORTING (Tables)
3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Schedule of segment information
                     
   March 31, 2025
   Biotechnology Segment  Technology
Segment
  Consolidated
Sales  $   $62,874   $62,874 
Cost of goods sold       45,156    45,156 
Total operating expenses   4,014,702    60,000    4,074,702 
Net loss from operations  $(4,014,702)  $(42,282)  $(4,056,984)
                
                
    March 31, 2024 
    

Biotechnology

Segment

    

Technology

Segment

    Consolidated 
Sales  $   $   $ 
Cost of goods sold            
Total operating expenses   2,922,383        2,922,383 
Net loss from operations  $(2,922,383)  $   $(2,922,383)